Robuta

Researchers have reported the discovery of a new therapeutic paradigm called Deubiquitinase Targeting Chimeras to address the challenge of targeted protein...

Scientists have developed a new approach to targeting key cancer-linked proteins, thought to be 'undruggable'.

Finding structure in disordered proteins and developing drugs for undruggable diseases: it might sound like mission impossible, but pharmacologist Alireza...

Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer

Alphabodies cross over the boundaries between biologics and small chemical drugs Complix NV, a biopharmaceutical company focused on the discovery and...

Despite more than three decades of intensive effort, no effective pharmacological inhibitors of the RAS oncoproteins have reached the clinic, prompting the...